TG Therapeutics, Inc(NASDAQ:TGTX) 
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclon...
Website: http://www.tgtherapeutics.com
Founded: 1993
Full Time Employees: 217
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 37.94
H 38.83
L 36.55
C 37.35
V 3,132,129
10EMA 37.35
20EMA 37.35
60EMA 37.35
120EMA 37.35
250EMA 37.35